Brainwave Healthcare Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 24-10-2024
- Paid Up Capital ₹ 0.10 M
as on 24-10-2024
- Company Age 16 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 9.90 M
as on 24-10-2024
- Revenue 28.52%
(FY 2023)
- Profit 106.07%
(FY 2023)
- Ebitda 91.66%
(FY 2023)
- Net Worth 51.25%
(FY 2023)
- Total Assets 23.71%
(FY 2023)
About Brainwave Healthcare
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹9.90 M.
Vimal Mehta, Parveen Kumar, and Ashish Kaushish serve as directors at the Company.
- CIN/LLPIN
U24232DL2008PTC178513
- Company No.
178513
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 May 2008
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Brainwave Healthcare?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vimal Mehta  | Director | 23-May-2008 | Current |
| Parveen Kumar | Director | 23-May-2008 | Current |
| Ashish Kaushish | Director | 01-Apr-2021 | Current |
Financial Performance of Brainwave Healthcare.
Brainwave Healthcare Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 28.52% increase. The company also saw a substantial improvement in profitability, with a 106.07% increase in profit. The company's net worth Soared by an impressive increase of 51.25%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Brainwave Healthcare?
In 2022, Brainwave Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Kedar Ayurveda Private LimitedActive 3 years 30 daysVimal Mehta, Parveen Kumar and 1 more are mutual person
- Kedar Drugs And Pharmaceuticals Private LimitedActive 2 years 9 months
Vimal Mehta and Parveen Kumar are mutual person
- Aitus Healthcare LimitedActive 20 years 7 months
Vimal Mehta, Parveen Kumar and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 12 Dec 2023 | ₹9.90 M | Open |
How Many Employees Work at Brainwave Healthcare?
Unlock and access historical data on people associated with Brainwave Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Brainwave Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Brainwave Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
